These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19385009)

  • 21. Thalidomide: an old sedative-hypnotic with anticancer activity?
    Gasparini G; Morabito A; Magnani E; Gattuso D; Capaccetti B; Alberti AM
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1302-8. PubMed ID: 11717819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Monoclonal antibodies in hematologic oncology].
    Kuliczkowski K; Podolak-Dawidziak M
    Pol Arch Med Wewn; 2002 May; 107(5):469-73. PubMed ID: 12189920
    [No Abstract]   [Full Text] [Related]  

  • 23. Highlights from the EORTC-NCI-AACR 2002 meeting: molecular targets and cancer therapeutics.
    Sausville E; Verweij J
    Clin Adv Hematol Oncol; 2003 Jan; 1(1):22-3. PubMed ID: 16227956
    [No Abstract]   [Full Text] [Related]  

  • 24. American Society of Pediatric Hematology/Oncology 18th Annual Meeting, Washington, D.C., May 13-16, 2005. Abstracts.
    Pediatr Blood Cancer; 2005 Jun; 44(6):529-82. PubMed ID: 15795885
    [No Abstract]   [Full Text] [Related]  

  • 25. Abstracts of the 8th Annual Meeting of the Hematology/Oncology Pharmacy Association. March 21-14, 2012. Orlando, Florida, USA.
    J Oncol Pharm Pract; 2012 Mar; 18(1 Suppl):5-22. PubMed ID: 22333736
    [No Abstract]   [Full Text] [Related]  

  • 26. 49th annual meeting of American Society of Hematology (Atlanta, Georgia, 8-11 December).
    Fricker J
    Mol Oncol; 2008 Apr; 1(4):379-83. PubMed ID: 19383311
    [No Abstract]   [Full Text] [Related]  

  • 27. Abstracts of the 9th Annual Meeting of the Hematology/Oncology Pharmacy Association. March 20-23, 2013. Los Angeles, California, USA.
    J Oncol Pharm Pract; 2013 Mar; 19(1 Suppl):5-17. PubMed ID: 23444476
    [No Abstract]   [Full Text] [Related]  

  • 28. Expanding role of monoclonal antibodies in the treatment of hematologic malignancies. Highlights from the 41st annual meeting of the American Society of Hematology. New Orleans, Louisiana, USA. December 3-7, 1999. Abstracts.
    Oncology (Williston Park); 2000 Mar; 14(3 Suppl 1):5-60. PubMed ID: 10808400
    [No Abstract]   [Full Text] [Related]  

  • 29. Abstracts of the Annual Meeting of the German and Austrian Society of Hematology and Oncology. Munich, Germany, 27-30 October 2002.
    Onkologie; 2002 Oct; 25 Suppl 4():1-303. PubMed ID: 12462220
    [No Abstract]   [Full Text] [Related]  

  • 30. German and Austrian Society of Hematology and Oncology annual meeting. Mannheim, Germany, September 30 - October 3, 2001. Abstracts.
    Onkologie; 2001 Sep; 24 Suppl 6():1-250. PubMed ID: 11727702
    [No Abstract]   [Full Text] [Related]  

  • 31. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 32. [Research on demethylation therapy for hematology malignancy].
    Shen JZ; Zhou HR
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):355-6. PubMed ID: 16780731
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ambulatory chemotherapy in hematology. A challenge ...].
    Montagne C; Duran B
    Soins; 1996 Sep; (608):62-8. PubMed ID: 8954491
    [No Abstract]   [Full Text] [Related]  

  • 34. Abstracts from the 5th Annual Meeting of the Hematology/Oncology Pharmacy Association, June 17-20, 2009, Miami, Florida, USA.
    J Oncol Pharm Pract; 2009 Jun; 15(2 Suppl):6-31. PubMed ID: 19470751
    [No Abstract]   [Full Text] [Related]  

  • 35. Summer happenings in Hematology 2011. Highlights in Hematological Malignancies form the 2011 American Society Clinical Oncology Annual Meeting and the 16th Congress of the European Hematology Association, and the 11th International Conference on Malignancy Lymphoma.
    Ashforth E; Cheson BD
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 17):1-24. PubMed ID: 22361949
    [No Abstract]   [Full Text] [Related]  

  • 36. Abstracts of the 3rd annual meeting of the Hematology/Oncology Pharmacy Association (HOPA), June 14-16, 2007.
    J Oncol Pharm Pract; 2007 Sep; 13(3):133-76. PubMed ID: 17933831
    [No Abstract]   [Full Text] [Related]  

  • 37. Preface. Combining clinical, translational and basic cancer drug research: the 2008 CESAR annual meeting.
    Brockmoeller J; Sehrt D; Scheulen ME
    Int J Clin Pharmacol Ther; 2009 Jan; 47(1):30-2. PubMed ID: 19203530
    [No Abstract]   [Full Text] [Related]  

  • 38. Bendamustine hydrochloride - a renaissance of alkylating strategies in anticancer medicine.
    Eichbaum M; Bischofs E; Nehls K; Schneeweiss A; Sohn C
    Drugs Today (Barc); 2009 Jun; 45(6):431-44. PubMed ID: 19649333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abstracts of the 5th International Symposium on Targeted Anticancer Therapies, 8-10 March 2007, Amsterdam, The Netherlands.
    Ann Oncol; 2007 May; 18 Suppl 4():iv17-50. PubMed ID: 17915341
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hematology: experiences with common national reports on new anti-cancer drugs].
    Kristensen JS; Bukh A
    Ugeskr Laeger; 2009 Mar; 171(13):1089. PubMed ID: 19321084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.